This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2021 Dec 1;42(45):4680-4682.

doi: 10.1093/eurheartj/ehab521.

What are the PROSPECTs and clinical implications of vulnerable plaque?

Rasha Al-Lamee¹, Gary S Mintz²

Affiliations

PMID: 34370846
DOI: 10.1093/eurheartj/ehab521

Editorial

What are the PROSPECTs and clinical implications of vulnerable plaque?

Rasha Al-Lamee et al. Eur Heart J. 2021.

. 2021 Dec 1;42(45):4680-4682.

doi: 10.1093/eurheartj/ehab521.

Authors

Rasha Al-Lamee¹, Gary S Mintz²

Affiliations

¹ National Heart and Lung Institute, Imperial College London, London UK.
² Cardiovascular Research Foundation, New York, NY, USA.

PMID: 34370846
DOI: 10.1093/eurheartj/ehab521

No abstract available

PubMed Disclaimer

Comment on

Thin-cap fibroatheroma predicts clinical events in diabetic patients with normal fractional flow reserve: the COMBINE OCT-FFR trial.
Kedhi E, Berta B, Roleder T, Hermanides RS, Fabris E, IJsselmuiden AJJ, Kauer F, Alfonso F, von Birgelen C, Escaned J, Camaro C, Kennedy MW, Pereira B, Magro M, Nef H, Reith S, Al Nooryani A, Rivero F, Malinowski K, De Luca G, Garcia Garcia H, Granada JF, Wojakowski W. Kedhi E, et al. Eur Heart J. 2021 Dec 1;42(45):4671-4679. doi: 10.1093/eurheartj/ehab433. Eur Heart J. 2021. PMID: 34345911 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems
Medical
- MedlinePlus Health Information